Literature DB >> 11563879

The fifth immunoglobulin-like domain of the Kit receptor is required for proteolytic cleavage from the cell surface.

V C Broudy1, N L Lin, D F Sabath.   

Abstract

Stem cell factor (SCF) initiates its biological effects by binding to its receptor Kit. Cell surface Kit is proteolytically cleaved to generate soluble Kit. Structure-function analysis of the extracellular region of Kit has implicated the first three immunoglobulin-like domains in SCF binding, and the fourth immunoglobulin-like domain in receptor dimerization. However, the role of the fifth immunoglobulin-like domain is unknown. To test the hypothesis that the fifth immunoglobulin-like domain is important for proteolytic cleavage of Kit from the cell surface, we constructed a mutant form of Kit in which the first four immunoglobulin-like domains are linked to the transmembrane and cytoplasmic domains (designated Kit-Del5). Kit-wild type (Kit-WT) and Kit-Del5 were expressed in the murine mast cell line IC2. Flow cytometry demonstrated that both Kit-WT and Kit-Del5 are displayed on the IC2 cell surface, and immunoblotting confirmed the presence of Kit proteins of the expected molecular weights, 154 kDa and 134 kDa, respectively. Although IC2-Kit-WT cells proteolytically cleave cell surface Kit, generating a 98 kDa soluble form of Kit, IC2-Kit-Del5 cells do not. These findings demonstrate that the fifth immunoglobulin-like domain of Kit is required for proteolytic cleavage of Kit from the cell surface. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563879     DOI: 10.1006/cyto.2001.0907

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.

Authors:  Syed Rizwan Hussain; Hena Naqvi; Farzana Mahdi; Cherry Bansal; Sunil G Babu
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

2.  A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells.

Authors:  Kwang-Hyeok Kim; Jin-Ock Kim; Sang Gyu Park
Journal:  Mol Cell Biochem       Date:  2022-09-15       Impact factor: 3.842

3.  The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification.

Authors:  Cen Qiu; Xiaohong Liu; Chenguang Bai; DA Lie Ma
Journal:  Oncol Lett       Date:  2012-07-11       Impact factor: 2.967

Review 4.  Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.

Authors:  Ilaria Marech; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2014-07-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.